Skip to main content
SpringerLink
Log in

Nutritional Management of the Uremic Patient

  • Chapter
Therapy of Renal Diseases and Related Disorders

Abstract

The dietary treatment of patients with chronic renal failure has many components. These include appropriate protein intake, sufficient adequate calories, and vitamins and trace element supplements (1). The clinical importance of the adequate dietary management of uremic patients is evident since uremia is characterized by a state of wasting and malnutrition (2–7).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Holliday MA: Nutrition therapy in renal disease. Kidney Int 30:3–6, 1986.

    Google Scholar 

  2. Blumenkrantz MJ, Kopple JD, Gutman RA, Chan YK, Barbour GL, Roberts C, Shen FH, Gandhi VC, Tucker CT, Curtis FK, Coburn JW: Methods for assessing nutritional status in patients with renal failure. Am J Clin Nutr 33:1567–1585, 1980.

    PubMed  CAS  Google Scholar 

  3. Bansal VK, Popli S, Pickering J, Ing TS, Vertuno LL, Hano JE: Protein-caloric malnutrition and cutaneous anergy in hemodialysis maintained patients. Am J Clin Nutr 33:1608–1611, 1980.

    PubMed  CAS  Google Scholar 

  4. Thunberg BJ, Swamy AP, Cestero RV: Cross-sectional and longitudinal nutritional measurements in maintenance hemodialysis patients. Am J Clin Nutr 34:2005–2012, 1981.

    PubMed  CAS  Google Scholar 

  5. Young GA, Swanepoel CR, Croft MR, Hobson SM: Anthropometry and plasma valine, amino acids and proteins in the nutritional assessment of hemodialysis patients. Kidney Int 21:492–499, 1982.

    PubMed  CAS  Google Scholar 

  6. Heide B, Pierratos A, Jhanna R, Pettit J, Ogilvje R, Harrison J, McNeil K, Siccion Z, Oreopoulos DG: Nutritional status of patients undergoing CAPD. Peritoneal Dial Bull 3:138–141, 1983.

    Google Scholar 

  7. Wolfson J, Strong CJ, Minturn D, Gray DK, Kopple JD: Nutritional status and lymphocyte function in maintenance hemodialysis patients. Am J Clin Nutr 37:547–555, 1984.

    Google Scholar 

  8. Alvestrand A, Ahlberg M, Bergstrom J: Retardation of the progression of renal insufficiency in patients treated with low protein diets. Kidney Int 24 (Suppl 16):268–272, 1983.

    Google Scholar 

  9. Mashio G, Oldrizzi L, Tessitore N, D’Angelo A, Valvo E, Lupo A, Loschiavo C, Fabris A, Gammaro L, Rugio C, Panzetta G: Early dietary protein and phosphorous restriction is effective in delaying progression of chronic renal failure. Kid Int 124 (Suppl 16): 273–277, 1983.

    Google Scholar 

  10. Rosman JB, Meijer S, Slinter WJ, ter Wee PM, Piers—Becht TPhM, Donker AJM: Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet 2:1291–1295, 1984.

    PubMed  CAS  Google Scholar 

  11. Guarnieri G, Toigo G, Situlin R, Crapesi L, Del Bianco MA, Zanettovich A, Faccini L, Lucchesi A, Oldrizzi L, Rugiu C, Maschio G: Nutritional assessment in patients with early renal insufficiency on long-term low protein diet. Contr Nephrol 53:40–50, 1986.

    CAS  Google Scholar 

  12. Acchiardo SR, Moore LW, Latour PA: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 24 (Suppl 16):199–203, 1983.

    Google Scholar 

  13. Kopple JD, Jones M, Fukuda S, Swendseid ME: Amino acid and protein metabolism in renal failure. Am J Clin Nutr 31:1532–1535, 1978.

    PubMed  CAS  Google Scholar 

  14. Bergström J: Discovery and rediscovery of low protein diet. Clin Nephrol 21:29–35. 1984.

    PubMed  Google Scholar 

  15. Kopple JD: Nutritional therapy in kidney failure. Nutr Rev 39:193–206, 1981.

    PubMed  CAS  Google Scholar 

  16. Alvestrand A, Bergström J: Nutritional management. In: WN Suki, SG Massry, eds, Therapy of Renal Diseases and Related Disorders. Martinus Nijhoff, Boston, pp 459–480, 1984.

    Google Scholar 

  17. Burge JC, Park HS, Whitlock CP, Schemmel RA: Taste acuity in patients undergoing long-term hemodialysis. Kidney Int 15:49–53, 1979.

    PubMed  CAS  Google Scholar 

  18. LI J, Wassner S: Protein synthesis and degradation in skeletal muscle of chronically uremic rats. Kidney Int 29:1136–1143, 1986.

    PubMed  CAS  Google Scholar 

  19. Garber A: Skeletal muscle protein and amino acid metabolism in experimental chronic uremia in the rat: Accelerated alanine and glutamine formation and release. J Clin Invest 62:623–632, 1978.

    PubMed  CAS  Google Scholar 

  20. Garber A: The regulation of skeletal muscle alanine and glutamine formation and release in experimental chronic uremia in the rat. J Clin Invest 62:633–641, 1978.

    PubMed  CAS  Google Scholar 

  21. Kopple JD: Nutrition in renal failure. In: RR Robinson, ed, Nephrology, Vol 2. Springer-Verlag, New York, pp 1498–1515, 1984.

    Google Scholar 

  22. De Fronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J: Insulin resistance in uremia. J Clin Invest 67:563–568, 1981.

    Google Scholar 

  23. Sherwin RS, Basti C, Finkelstein FO, Fisher M, Black H, Hendler R, Felig P: Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon. J Clin Invest 57:722–731, 1976.

    PubMed  CAS  Google Scholar 

  24. Kopple JD, Cianciaruso B, Massry SG: Does parathyroid hormone cause protein wasting? Contr Nephrol 20:138–148, 1980.

    CAS  Google Scholar 

  25. Bondy PK, Engel FL, Farrar B: The metabolism of amino acids and protein in the adrenalectomized nephrectomized rat. Endocrinology 44:476–483, 1949.

    PubMed  CAS  Google Scholar 

  26. Schaefer RM, Teschner M, Kulzer P, Leipold J, Peter G, Heidland A: Evidence for reduced catabolism by the anti-glucocorticoid RU 38486 in acutely uremic rats. Am J Nephrol 7:127–131, 1987.

    PubMed  CAS  Google Scholar 

  27. May R, Kelly R, Mitch W: Metabolic acidosis stimulates protein degradation in rat muscle by glucocorticoid dependent mechanism. J Clin Invest 77:614–621, 1986.

    PubMed  CAS  Google Scholar 

  28. Teschner M, Heidland A: Nutrition in acute renal failure Blood Purif 3:170–178, 1985.

    PubMed  CAS  Google Scholar 

  29. Cerra FB, Siegel JH, Coleman B, Border JR, McMenamy RR: Septic autocannibalism: Failure of exogenous nutritional support. Ann Surg 192:570–580, 1980.

    PubMed  CAS  Google Scholar 

  30. Clowes GHA, George BC, Villee CA, Saravis CA: Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med 308:545–552, 1983.

    PubMed  Google Scholar 

  31. Baracos V, Rodemann P, Dinarello CA, Goldberg AL: Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (Interleukin 1). N Engl J Med 308:553–558, 1983.

    PubMed  CAS  Google Scholar 

  32. Goldberg AL, Baracos VE, Rodemann P, Waxmann L, Dinarello CA: Control of protein degradation in muscle by prostaglandins, Ca2+, and leukocytic pyrogen (interleukin 1). Fed Proc 1301–1306, 1984.

    Google Scholar 

  33. Dinarello CA, Wolff SM: Molecular basis of fever in humans. Am J Med 72:799–819, 1982.

    PubMed  CAS  Google Scholar 

  34. Baracos VE, Wilson JE, Goldberg AL: Effects of temperature on protein turnover in isolated rat skeletal muscle. Am J Physiol 246:125–130, 1984.

    Google Scholar 

  35. Monteon FJ, Laidlaw SA, Shaib JK, Kopple JD: Energy expenditure in patients with chronic renal failure. Kidney Int 30:741–747, 1986.

    PubMed  CAS  Google Scholar 

  36. Levine SE, Madnnis MA:Pitfalls of nutritional assessment in end-stage renal disease: A case approach. Dial Transpl 14:610–617, 1985.

    Google Scholar 

  37. Madden JP, Goodman SJ, Guthrie HA: Validity of the 24-hr recall. J Am Diet Assoc 68:143–147, 1976.

    PubMed  CAS  Google Scholar 

  38. Gersovitz M, Madden JP, Smiciklas-Wright H: Validity of the 24-hr dietary recall and seven-day recall for group comparisons. J Am Diet Assoc 73:48–55, 1978.

    PubMed  CAS  Google Scholar 

  39. El Nahas AM, Coles GA: Dietary treatment of chronic renal failure: Ten unanswered questions. Lancet 2:597–600, 1986.

    Google Scholar 

  40. Holliday MA, McHenry-Richardson K, Portale A: Nutritional management of chronic renal disease. Med Clin North Am 63:945–963, 1979.

    PubMed  CAS  Google Scholar 

  41. Kopple JD, Colwin JW: Evaluation of chronic uremia. Importance of serum urea nitrogen, serum creatinine and their ratio. JAMA 277:41–44, 1974.

    Google Scholar 

  42. Grodstein G, Kopple JD: Urea nitrogen appearance, a simple and practical indicator of total nitrogen output (abstract). Kidney Int 16:953, 1979.

    Google Scholar 

  43. Mitch WE, Walser M: Nutritional therapy of the uremic patients. In: BM Brenner, FC Rector, eds, The Kidney, Vol 2. WB Saunders, Philadelphia, pp 1759–1790, 1986.

    Google Scholar 

  44. Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 21:849–861, 1982.

    PubMed  CAS  Google Scholar 

  45. Maroni BJ, Steinman TI, Mitch WE: A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27:58–65, 1985.

    PubMed  CAS  Google Scholar 

  46. Kopple JD, Swenseid ME: Amino acid and keto acid diet for therapy in renal failure. Nephron 18:1–12, 1977.

    PubMed  CAS  Google Scholar 

  47. Ritz E, Mehls O, Gilli G, Heuck CC: Protein restriction in the conservative management of uremia. Am J Clin Nutr 31:1703–1711, 1978.

    PubMed  CAS  Google Scholar 

  48. Berkelhammer CH, Leiler LA, Jeejeebhoy KN, Detsky AS, Oreopoulos DG, Uldall PR, Baker JP: Skeletal muscle function in chronic renal failure: An index of nutritional status. Am J Clin Nutr 42:845–854, 1985.

    PubMed  CAS  Google Scholar 

  49. Flynn MA: Nutritional problems in continous ambulatory peritoneal dialysis. Perit Dial Bull 4 (Suppl):142–146,1984.

    Google Scholar 

  50. Goldsmith GA: Nutritional Diagnosis. Charles C Thomas, Springfield, IL, 1959.

    Google Scholar 

  51. Cohn S, Brennan BL, Yasamara S, Vartsky D, Vaswani AN, Ellis KJ: Evaluation of body composition and nitrogen content of renal patients on chronic dialysis as determined by total body nitrogen activation. Am J Clin Nutr 38:52–58, 1983.

    PubMed  CAS  Google Scholar 

  52. Garrow JS: New approaches to body composition. Am J Clin Nutr 35:1152–1158, 1982.

    PubMed  CAS  Google Scholar 

  53. Seedat YK: Exchangeable potassium study in patients undergoing chronic hemodialysis. Brit Med J 2:344–347, 1969.

    PubMed  CAS  Google Scholar 

  54. Bilbrey GLNW, Carter MG, White J, Schilling F, Knochel JP: Potassium deficiency in chronic renal failure. Kidney Int 4:423–428, 1973.

    PubMed  CAS  Google Scholar 

  55. Letteri JM, Ellis KJ, Asad SN, Cohn SH: Serial measurement of total body potassium in chronic renal disease. Am J Clin Nutr 31:1937–1944, 1978.

    PubMed  CAS  Google Scholar 

  56. Schilling H, Wu G, Pettit J, Harrison J, McNeil K, Siccion Z, Oreopoulus DG: Nutritional status of patients on long-term CAPD. Perit Dial Bull 5:12–18, 1985.

    Google Scholar 

  57. Jeejeebhoy K, Baker JP, Wolman SL, Wesson DE, Langer B, Harrison JE, McNeill KG: Critical evaluation on the role of clinical assessment and body compositon studies in patients with malnutrition and after total parenteral nutrition. Am J Clin Nutr 35:1117–1127, 1982.

    PubMed  CAS  Google Scholar 

  58. Collins JP, McCarthy ID, Hill GL: Assessment of protein nutrition in surgical patients — the value of anthropometrics. Am J Clin Nutr 32:1527–1530, 1979.

    PubMed  CAS  Google Scholar 

  59. Forse RA, Shizgal HM: The assessment of malnutritions. Surgery 88:17–24, 1980.

    PubMed  CAS  Google Scholar 

  60. Buzby GP, Mullen JL, Matthews DC, Hobbs CI, Rosate EF: Prognostic nutritional index in gastrointestinal surgery. Am J Surg 139:160–167, 1980.

    PubMed  CAS  Google Scholar 

  61. Schaefer G, Heinze V, Jontofsohn R, Katz N, Rippich Th, Schäfer B, Südhoff A, Zimmermann W, Kluthe R: Amino acid and protein intake in RDT patients — a nutritional and biochemical analysis. Clin Nephrol 3:228–233, 1975.

    Google Scholar 

  62. Heidland A, Kult J: Long-term effects of essential amino acids supplementation in patients on regular dialysis treatment. Clin Nephrol 3:234–239, 1975.

    PubMed  CAS  Google Scholar 

  63. Jensen TG, Englert AM, Dudrick SJ: Interpretation assessment data. Nutr Suppl Serv 1:14–20, 1981.

    Google Scholar 

  64. Shetty PS, Jung RT, Watrasiewicz KE, James WPT: Rapid turnover transport proteins: An index of subclinical protein-energy malnutrition. Lancet 2:230–232, 1979.

    PubMed  CAS  Google Scholar 

  65. Golden M: Transport proteins as indices of protein status. Am J Clin Nutr 35:1159–1165, 1982.

    PubMed  CAS  Google Scholar 

  66. Peters JP: Malnutrition and edema. Nutr Rev 8:33–36, 1950.

    Google Scholar 

  67. McFarlane H, Ogbeide MJ, Reddy S, Adcock JK, Adishina H, Gurney JM, Cooke A, Taylor GO, Mordie JA: Biochemical assessment of protein-calorie malnutrition. Lancet 1:392–396, 1969.

    PubMed  CAS  Google Scholar 

  68. Kluthe R, Baumann G, Beschoff V, Quirin H: Serum transferrin und Eiweißernährung bei chronisch intermittierender Hämodialyse. Med Ernährung 12:73–77, 1971.

    Google Scholar 

  69. Miller DG, Levine S, Bistrian B: Diagnosis of protein calorie malnutrition in diabetic patients on hemodialysis and peritoneal dialysis. Nephron 33:127–132, 1983.

    PubMed  CAS  Google Scholar 

  70. Schoenfeld PY, Henry RR, Laird NM, Roxe DM: Assessment of nutritional status of the national cooperative dialysis study population. Kidney Int 23 (Suppl 13):80–88, 1983.

    Google Scholar 

  71. Peterson PA: Demonstration in serum of two physiological forms of the human retinol binding. J Clin Invest 1:437–444, 1971.

    CAS  Google Scholar 

  72. Young GA, Keogh JB, Parson FM: Plasma amino acids and protein levels in chronic renal failure and changes caused by oral supplements of essential amino acids. Clin Chim Acta 61:205–213, 1975.

    PubMed  CAS  Google Scholar 

  73. Mogielnicki RP, Waldmann TA, Strober W: Renal handling of low molecular weight proteins. 1. L-chain metabolism in experimental renal disease. J Clin Invest 50:901–909, 1971.

    PubMed  CAS  Google Scholar 

  74. Volhard F: Die doppelScitigen hämatogenen Nierenerkrankungen (Bright’sche krankheit). In: Mohr, Stachelin, Handbuch der Inneren Medizin. Springer, Berlin, pp 1149–1722, special page 1400, 1918.

    Google Scholar 

  75. Walser M, Mitch WE, Abras E: Supplements containing amino acids and keto acids in the treatment of chronic uremia. Kidney Int 24 (Suppl 16):285–289, 1983.

    CAS  Google Scholar 

  76. Schreiner GE, Maher JF: In: IN Kugelmass, ed, Uremia, Biochemistry, Pathogenesis and Treatment. Charles C Thomas, Springfield, IL. p 81, 1961.

    Google Scholar 

  77. Walser M: Determinants of ureogenesis with particular reference to renal failure. Kidney Int 17:709–721, 1980.

    PubMed  CAS  Google Scholar 

  78. Simmons WK: The plasma amino acid ratio as an indicator of the protein nutrition status: A review of recent work. Bull World Health Org 42:480–482, 1970.

    PubMed  CAS  Google Scholar 

  79. Fürst P, Alvestrand A, Bergström J: Effects of nutrition and catabolic stress on intracellular amino acid pools in uremia. Am J Clin Nutr 33:1387–1395, 1980.

    PubMed  Google Scholar 

  80. Giordano CC, de Pascale C, Pluvio M, De Santo NG, Fella A, Esposito R, Capasso G, Pota A: Adverse effects among amino acids in uremia. Kidney Int 7:306–310, 1975.

    Google Scholar 

  81. Harper AE, Benevenga NJ, Wolhuetin RM: Effects of ingestion of disproportionate amounts of amino acids. Physiol Rev 50:428–435, 1970.

    PubMed  CAS  Google Scholar 

  82. Waterlow JC, Garlick PJ, Millward DJ: Protein Turnover In Mammalian Tissues and in Whole Body. North-Holland, Amsterdam, New York, 1978.

    Google Scholar 

  83. Giovannetti S, Maggiore Q: A low-nitrogen diet with proteins of high biological value for severe chronic uremia. Lancet 1:1000–1005, 1964.

    PubMed  CAS  Google Scholar 

  84. Rose WC: The amino acid requirements of adult man. Nutr Abstr Rev 27:631–647, 1957.

    CAS  Google Scholar 

  85. Giordano C: Use of exogenous and endogenous urea for protein synthesis in normal and uremic subjects. J Lab Clin Med 62:231–246, 1963.

    PubMed  CAS  Google Scholar 

  86. Berlyne GM, Shaw AB, Nilwarangkur S: Dietary treatment of chronic renal failure. Experiences with modified Giovanetti diet. Nephron 2:129–134, 1965.

    PubMed  CAS  Google Scholar 

  87. Boström H, Edgren B, Engelke B: Experiences with the Giovanetti diet in chronic uremia. Scand J Urol Nephrol 1:171–176, 1967.

    Google Scholar 

  88. Kluthe R, Oechslen D, Quirin H, Jesdinsky HJ: Six years’ experience with a special low-protein diet. In: R Kluthe, G Berlyne, B Burton, eds, Uremia. Thieme, Stuttgart, p 250, 1972.

    Google Scholar 

  89. Hodd CEA, Beale DJ, Housley J, Hardwicke J: Dialysed egg as nitrogen source in dietary control of chronic renal failure. Lancet 1:8–14, 1969.

    Google Scholar 

  90. Lonergan ET, Lange K: Use of special protein-restricted diet in uremia. Am J Clin Nutr 21:595–605, 1968.

    PubMed  CAS  Google Scholar 

  91. Carmena R, Shapiro FL: Dietary management of chronic renal failure. Geriatrics 79:95–102, 1972.

    Google Scholar 

  92. Ford J, Phillips ME, Toye FE, Luck VA, de Wardener HE: Nitrogen balance in patients with chronic renal failure on diets containing varying quantities of protein. Br Med J 1:735–737, 1969.

    PubMed  CAS  Google Scholar 

  93. Kopple JD, Sörensen MK, Coburn JW, Gordon S, Rubini ME: Controlled comparison of 20g and 40g protein diets in the treatment of chronic uremia. Am J Clin Nutr 21:553–564, 1968.

    PubMed  CAS  Google Scholar 

  94. Kopple JD, Coburn JW: Metabolic studies of low protein diets in uremia. I. Nitrogen and potassium. Medicine 52:583–595, 1973.

    PubMed  CAS  Google Scholar 

  95. Giovanetti S: Low protein diet in chronic uremia: A historical survery. Contr Nephrol 3:1–6, 1986.

    Google Scholar 

  96. Giovanetti S: Dietary treatment of chronic renal failure. Why is it not used more frequently? Nephron 40:1–12, 1985.

    Google Scholar 

  97. Bergström J, Fürst P, Noree LO: Treatment of chronic uremic patients with protein-poor diet and oral supply of essential amino acids. I. Nitrogen balance studies. Clin Nephrol 3:187–194, 1975.

    PubMed  Google Scholar 

  98. Edozien JC: The free amino acids of plasma and urine in Kwashiorkor. Clin Sci 31:153–161, 1966.

    PubMed  CAS  Google Scholar 

  99. Chan W, Wang M, Kopple JD, Swendscid ME: Citrulline levels and urea cycle enzymes in uremic rats. J Nutr 104:678–683, 1974.

    PubMed  CAS  Google Scholar 

  100. Young GA, Parsons FM: Impairment of phenylalanine hyd-roxylation in chronic renal insufficiency. Clin Sci 45:89–97, 1973.

    PubMed  CAS  Google Scholar 

  101. Wang M, Vyhmeister I, SwendScid ME, Kopple JD: Phenylalanine hydroxylase and tyrosine aminotransferase activity in chronically uremic rats. J Nutr 105:122–127, 1975.

    CAS  Google Scholar 

  102. Jones MR, Kopple JD: Valine metabolism in normal and chronically uremic man. Am J Clin Nutr 31:1660–1664, 1978.

    PubMed  CAS  Google Scholar 

  103. Saito A, Niwa T, Maeda K, Kobayashi K, Yamamoto Y, Ohata K: Tryptophan and indolic tryptophan metabolites in chronic renal failure. Am J Clin Nutr 33:1402–1406, 1980.

    PubMed  CAS  Google Scholar 

  104. Ahlmen J: Incidence of chronic renal insufficiency. A study of the incidence and pattern of renal insufficiency in adults during 1966–1971 in Gothenberg. Acta Med Scand Suppl 582:S3, 1975.

    Google Scholar 

  105. Tizianello A, DeFerrari G, Garibotto G, Gurneri G, Robando C: Renal metabolism of amino acids and amonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest 65:1162–1173, 1980.

    PubMed  CAS  Google Scholar 

  106. Alvestrand A, Fürst P, Bergström J: Plasma and muscle free amino acids in uremia: Influence of nutrition with amino acids. Clin Nephrol 18:297–305, 1982.

    PubMed  CAS  Google Scholar 

  107. Alvestrand A, Ahlberg M, Fürst P, Bergström J: Clinical results of long-term treatment with a low protein diet and a new amino acid preparation in patients with chronic uremia. Clin Nephrol 19:67–73, 1983.

    PubMed  CAS  Google Scholar 

  108. Walser M, Coulter AW, Dighe S, Crantz FR: The effect of keto-analogues of essential amino acids in severe chronic uremia. J Clin Invest 52:678–690, 1973.

    PubMed  CAS  Google Scholar 

  109. Mitch WE, Collier VU, Walser M: Treatment of chronic renal failure with branched chain keto acids plus the other essential amino acids or their nitrogen free analogues. In: M Walser, JR Williamson, eds, Metabolic and Clinical Implications of Branched Chain Amino and Keto Acids. Elsevier/ North-Holland, New York, p 587, 1981.

    Google Scholar 

  110. Schloerb RR: Essential L-amino acid administration in uremia. Am J Med Sci 252:650–657, 1966.

    PubMed  CAS  Google Scholar 

  111. Mitch WE, Walser M: Nitrogen balance of uremic patients receiving branched-chain keto acids and the hydroxy-analogue of methionine as substitutes for the respective amino acids. Clin Nephrol 8:341–344, 1977.

    PubMed  CAS  Google Scholar 

  112. Mitch WE, Walser M: Utilization of calcium L-phenylacetate as a substitute for phenylalanine by uremic subjects. Metabolism 26:1041–1046, 1977.

    PubMed  CAS  Google Scholar 

  113. Walser M: Keto acids in the treatment of uremia. Clin Nephrol 3:180–186, 1975.

    PubMed  CAS  Google Scholar 

  114. Heidland A, Kult J, Röckel A, Heidbreder E: Evaluation of essential amino acids and keto acids in uremic patients on low-protein diet. Am J Clin Nutr 31:1784–1792, 1978.

    PubMed  CAS  Google Scholar 

  115. Schmicker R, Vetter K, Kaschube I, Goetz KH, Fröhling P: Comparison between essential amino acid and keto acid substituted diet in patients with chronic renal failure (abstract). Kidney Int 24 (Suppl 16):350, 1983.

    Google Scholar 

  116. Mitch WE, Abras E, Walser M: Long-term effects of a new keto acid supplement in patients with chronic renal failure. Kidney Int 22:48–53. 1982.

    PubMed  CAS  Google Scholar 

  117. Walser M: Conservative management of the uremic patient. In: B Brenner, FC Rector, eds, The Kidney. WB Saunders, Philadelphia, pp 383–2424, 1981.

    Google Scholar 

  118. Jones R, Dalton N, Turner C, Start K, Haycock G, Chantler C: Oral essential amino acid and keto acid supplements in children with chronic renal failure. Kidney Int 24:95–103, 1983.

    PubMed  CAS  Google Scholar 

  119. Barsotti G, Guiducci A, Ciardella F, Giovannetti S: Effects on renal function of a low-nitrogen diet supplemented with essential amino acids and keto analogues and of hemodialysis and free protein supply in patients with chronic renal failure. Nephron 27:113–117, 1981.

    PubMed  CAS  Google Scholar 

  120. Mitch WE, Walser M, Steinman TI, Hill S, Zeger S, Tungasanga K: The effect of a ketoacid/amino acid supplement to a restricted diet on the progression of chronic renal failure. N Engl J Med 311:623–629, 1984.

    PubMed  CAS  Google Scholar 

  121. Broyer M, Guillor M, Niaudet P, Kleinknecht C, Dartois AM, Jean G: Comparison of three low-protein diets containing essential amino acids and their alpha analogues for severely uremic children. Kidney Int 24 (Suppl 16):290–294, 1983.

    Google Scholar 

  122. Barsotti G, Morelli E, Guiducci A, Ciardella F, Giannoni A, Luppatti S, Giovannetti S: Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet. Nephron 30:310–313, 1982.

    PubMed  CAS  Google Scholar 

  123. Barsotti G, Morelli E, Giannoni A, Guiducci A, Lupetti S, Giovannetti S: Restricted phosphorus and nitrogen intake to slow the progression of chronic renal failure. A controlled trial. Kidney Int 16:278–284, 1983.

    Google Scholar 

  124. Mitch WE, Walser M, Sapir DG: Nitrogen-sparing induced by leucine compared with that induced by its keto-analogue, a-ketoisoaproate in fasting obese man. J Clin Invest 67:553–562, 1981.

    PubMed  CAS  Google Scholar 

  125. Sapir DG, Steward PM, Walser M: Effects of a-ketoisocaproate and of leucine on nitrogen metabolism in postoperative patients. Lancet 1:1010–1013, 1983.

    PubMed  CAS  Google Scholar 

  126. Burns J, Cresswell E, Ell S, Fynn M, Jackson MA, Lee HA, Richards P, Rowlands A, Talbot S: Comparison of the effects of keto acid analogues and essential amino acids on nitrogen homeostasis in uremic patients on moderately protein-restricted diets. Am J Clin Nutr 31:1767–1775, 1978.

    PubMed  CAS  Google Scholar 

  127. Hecking E, Andrzejewski L, Prellwitz W, Opferkuch W, Müller D: Double-blind cross-over study with oral alpha-ketoacids in patients with chronic renal failure. Am J Clin Nutr 33:1678–1681, 1980.

    PubMed  CAS  Google Scholar 

  128. Epstein CM, Chawla RK, Waldsworth A, Rudman D: Decarboxylation of alpha-ketoisovaleric acid after oral administration in man. Am J Clin Nutr 33:1968–1974, 1980.

    PubMed  CAS  Google Scholar 

  129. Jackson MA, Lee HA: Changes in serum calcium caused by supplementation of low protein diets with keto-acid analogues in patients with chronic renal failure. J Parenter Enter Nutr 5:52–56, 1981.

    CAS  Google Scholar 

  130. Walser M: Keto-analogues of essential amino acids in the treatment of chronic renal failure. Kidney Int 13 (Suppl 8):180–184, 1978.

    Google Scholar 

  131. Lucas PA, Meadows JH, Roberts DE, Coles GA: The risks and benefits of a low protein-essential amino acid-keto acid diet. Kidney Int, in press.

    Google Scholar 

  132. Rand WM, Uauy R, Scrimshaw NW (eds): Protein Energy Requirement in Developing Countries: Results of International Research. FAO/WHO/UNU, United National Bulletin, Supplement 10, p 327, 1984.

    Google Scholar 

  133. FAO/WHO: Joint FAO/WHO Ad Hoc Committee on Energy and Protein Requirements. Technical Report Series # 522, World Health Organization, Geneva, 1973.

    Google Scholar 

  134. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Nephron 31:103–110, 1982.

    PubMed  CAS  Google Scholar 

  135. Ono K, Sasaki T, Waki Y: Glucose in the dialysate does not reduce the free amino acid loss during routine hemodialysis of non-fasting patients. Clin Nephrol 21:106–109, 1984.

    PubMed  CAS  Google Scholar 

  136. Phillips ME, Havard J, Hovard JP: Oral essential amino acid supplementation in patients on maintenance hemodialysis. Clin Nephrol 9:241–248, 1978.

    PubMed  CAS  Google Scholar 

  137. Levine SE: Nutritional care of patients with renal failure and diabetis. J Am Diet Assoc 81:261–265, 1982.

    PubMed  CAS  Google Scholar 

  138. Braverman D, Bogoch A: Metoclopramide for gastroparesis diabeticorum. Diabetis Care 1:356–361, 1978.

    CAS  Google Scholar 

  139. Walser M: Nutritional support in renal failure: Future directions. Lancet 1:340–341, 1983.

    PubMed  CAS  Google Scholar 

  140. Bergström J: Protein catabolic factors in patients on renal replacement therapy. Blood Purif 3:215–236, 1985.

    PubMed  Google Scholar 

  141. Hecking E, Distler A, Dörr R, Mader H, Port FK, Zobel R: Losses of amino acids into the dialysate, Benefits of intravenous or oral substitution of amino acids in patients on chronic intermittent hemodialysis. Akt Ernährungsemd 2:15–20, 1977.

    Google Scholar 

  142. Klinkmann H, Holtz M: The permeating of essential amino acids through different dialysis membranes. Proc EDTA 9:402–408, 1972.

    CAS  Google Scholar 

  143. Kopple JD, SwendScid ME, Shinaberger JH, Umezava ChY: The free and bound amino acids removed by hemodialysis. Trans Am Soc Artif Intern Org 19:309–316, 1973.

    CAS  Google Scholar 

  144. Aviram A, Peters JH, Gulyassy PF: Dialysance of amino acids and related substances. Nephron 8:440–454, 1971.

    PubMed  CAS  Google Scholar 

  145. Wofson M, Jones MR, Kopple JD: Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 21:500–506, 1982.

    Google Scholar 

  146. Möhring K, Sinn H, Schüler HW, Horsch R, Krüger H, Asbach HW: Comparison evaluation of iatrogenic sources of blood loss during maintenance dialysis. Proc EDTA 13:233–238, 1976.

    Google Scholar 

  147. Kluthe R, Lüttgen FM, Capetianu T, Heinze U, Katz N, Südhoff A: Protein requirements in maintenance hemodialysis. Am J Clin Nutr 31:1812–1820, 1978.

    PubMed  CAS  Google Scholar 

  148. Heidland A, Hörl WH, Heller N, Heine H, Neumann S, Schaefer RM, Heidbreder E: Granulocyte lysosomal factors and plasma elastase in uremia: A potential factor of catabol-ism. Klin Wschr 62:218–224, 1984.

    PubMed  CAS  Google Scholar 

  149. Hendersen LW, Koch KM, Dinarello CA, Shaldon S: Hemodialysis hypotension: The interleukin hypothesis. Blood Purif 1:3–8, 1983.

    Google Scholar 

  150. Alvestrand A, Gutierrez A, Wahren J, Bergström J: Blood-membrane interaction without dialysis induces increased protein catabolism in normal man (abstract). In: Fourth International Congress on Nutrition and Metabolism in Renal Disease, Williamsburg, VA, USA, 1985.

    Google Scholar 

  151. Feinstein EI: Parenteral nutrition in acute renal failure. Am J Nephrol 5:145–149, 1985.

    PubMed  CAS  Google Scholar 

  152. Vincenti F, Amend WJ, Abele J, Feduska NJ, Salvatierra O: The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 68:363–369, 1980.

    PubMed  CAS  Google Scholar 

  153. Frank W, Rao TKS, Manis T: Uremic hyperlipoproteinemia: Correlation with residual renal function and duration of maintenance hemodialysis. Trans Am Soc Artif Intern Org 23:59–63, 1977.

    CAS  Google Scholar 

  154. Lundin AP, Adler AJ, Feinroth MV, Berlyne GM, Friedman EA: Maintenance hemodialysis: Survival beyond the first decade. JAMA 244:38–40, 1980.

    PubMed  Google Scholar 

  155. Neff MS, Eiser AR, Scifkin RF, Baum M, Baez A, Gupta S, Amarga E: Patients surviving: 10 years of hemodialysis. Am J Med 74:996–1004, 1983.

    PubMed  CAS  Google Scholar 

  156. Gross RL, Newberne PM: Role of nutrition in immunologic function. Phyiol Rev 60:188–302, 1980.

    CAS  Google Scholar 

  157. Law DK, Dudrick SV, Abdon NI: Immunoincompetence of patients with protein-calorie malnutrition. Ann Intern Med 79:545–550, 1973.

    PubMed  CAS  Google Scholar 

  158. Hobbs CL, Murray TG, Mullen JL: Implications of malnutrition in chronic renal hemodialysis patients. J Par enter Enter Nutr 3:1, 1979.

    Google Scholar 

  159. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription on patient morbidity: Report from the National Cooperative Dialysis Study. N Engl J Med 305:1176–1181, 1981.

    PubMed  CAS  Google Scholar 

  160. Held E, Winkelmann W, Finke K, von Dohn H, Seyffart G, Gurland HJ: Plasma amino acids in chronic renal failure. Klin Wschr 52:974–978, 1974.

    CAS  Google Scholar 

  161. Kopple JD, Swendscid ME: Protein and amino acid metabolism in uremic patients undergoing maintenance hemodialysis. Kidney Int 7:64–72, 1975.

    Google Scholar 

  162. Kopple JD: Abnormal amino acid and protein metabolism in uremia. Kidney Int 14:340–348, 1978.

    PubMed  CAS  Google Scholar 

  163. Guarnieri G, Faccini L, Lipartiti T, Ranieri F, Spangaro F, Giuntini D, Toigo G, Dardi F, Raimondi A: Simple methods for nutritional assessment in hemodialysis patients. Am J Clin Nutr 33:1598–1607, 1980.

    PubMed  CAS  Google Scholar 

  164. SwendScid ME, Wang M, Schutz I, Kopple JD: Metabolism of urea cycle intermediates in chronic renal failure. Am J Clin Nutr 31:1581–1587, 1978.

    Google Scholar 

  165. Richards V, Hobbs C, Murray T, Mullen J: Incidence and sequelae of malnutrition (MNUT) in chronic hemodialysis (HD) patients (abstract). Kidney Int 14:683, 1978.

    Google Scholar 

  166. Munro HN: Energy and protein intakes as determinants of nitrogen balance. Kidney Int 14:313–316, 1978.

    PubMed  CAS  Google Scholar 

  167. Garza CN, Scrimshaw NS, Young VR: Human protein requirements: The effect of variations in energy intake within the maintenance range. Am J Clin Nutr 29:280–286, 1976.

    PubMed  CAS  Google Scholar 

  168. Comty CM, Shapiro FL: Hemodialysis. In: RJ Classock, ed, Current Therapy in Nephrology and Hypertension 1984–1985. BC Decker, New York, pp 261–268, 1984.

    Google Scholar 

  169. Borah MF, Schoenfeld PY, Gotch FA, Sargent FJA, Wolfson M, Humphreys MH: Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 14:491–500, 1978.

    PubMed  CAS  Google Scholar 

  170. Kopple JD, Shinaberger JH, Coburn JW, Sorensen M, Rubini ME: Optimal dietary protein treatment during chronic hemodialysis. Trans Am Soc Artif Intern Org 15:302–307, 1969.

    CAS  Google Scholar 

  171. Massry SG, Coburn JW, Peacock M, Kleeman CR: Turnover of endogenous parathyroid hormone in uremic patients and those undergoing hemodialysis. Trans Am Soc Artif Intern Org 18:416–422, 1972.

    CAS  Google Scholar 

  172. Fürst P, Bergström J, Josephson B, Norée LO: The effect of dialysis and administration of essential amino acids on plasma and muscle protein synthesis, studied with 15 N in uremic patients. EDTA 7:175–180, 1970.

    Google Scholar 

  173. Acchiardo S, Moore L, Cockrell S: Long term effect of essential amino acids on chronic hemodialysis patients (abstract). Kidney Int (Suppl 16):345, 1983.

    Google Scholar 

  174. Grodstein G, Harrison A, Roberts C, Ippoliti A, Kopple J: Impaired gastric emptying in hemodialysis patients (abstract). Kidney Int 16:952, 1979.

    Google Scholar 

  175. Young GA, Parson FM: Amino nitrogen loss during hemodialysis, its dietary significance and replacement. Clin Sci 31:299–307, 1966.

    PubMed  CAS  Google Scholar 

  176. Feinstein EI, Collins JF, Blumenkrantz MJ, Roberts M, Kopple JD, Massary SG: Nutritional Hemodialysis. In: K Atsami, M Maekawa, K Ota, eds, Progress in Artificial Organs. SAO Press, Cleveland, p 421, 1984.

    Google Scholar 

  177. Oreopoulos DG, Robson M, Faller B, Ogilvie R, Rapoport A, DeVeber GA: continuous ambulatory peritoneal dialysis: A new era in the treatment of chronic renal failure. Clin Nephrol 11:125–128, 1979.

    PubMed  CAS  Google Scholar 

  178. Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK: Continuous ambulatory peritoneal dialysis. Ann Intern Med 88:449–456, 1978.

    PubMed  CAS  Google Scholar 

  179. Nolph KD, Sorkin M, Rubin J: Continuous ambulatory peritoneal dialysis: Three-year experience at one center. Ann Intern Med 92:609–613, 1980.

    PubMed  CAS  Google Scholar 

  180. Oren A, Wu G, Anderson GH, Marliss E, Khanna R, Pettit J, Mupas L, rodella H, Brandes L, Roncari DA, Kakis G, Harrison J, McNeil K, Oreopoulos DG: Effective use of amino acid dialysate over four weeks in CAPD patients. Perit Dial Bull 3:66–73, 1983.

    Google Scholar 

  181. Salusky IB, Fine AN, nelson B, Blumenkrantz MJ, Kopple JD: Nutritional status of children undergoing continuous ambulatory peritoneal dialysis. Am J Clin Nutr 38:599–611, 1983.

    PubMed  CAS  Google Scholar 

  182. Moncrief JW, Popovich RO, Nolph KD, Rubin J, Robson M, Dombros N, De Veber GA, Oreopoulos DG: Clinical experience with the continuous ambulatory peritoneal dialysis. Am Soc Artif Intern Organs 2:114–118, 1979.

    Google Scholar 

  183. Kurtz SB, Wong VH, Andersson CF, vogel JP, McCarthy JT, Mitchell JC: Continuous ambulatory peritoneal dialysis. Three-years experience at the Mayo Clinic. Mayo Clin Proc 58:633–639, 1983.

    PubMed  CAS  Google Scholar 

  184. Lindholm B, Bergström J: Nutritional aspects of CAPD. In: gokal R, ed. Continuous ambulatory peritoneal dialysis. Churchill Livingstone, London, in press.

    Google Scholar 

  185. Lindholm B, Bergström J, Alvestrand A: Muscle free amino acids in patients treated with CAPD, In: Proceedings of the III International Sympsium on Peritoneal Dialysis, 1984, Washington DC, in press.

    Google Scholar 

  186. Williams P, Kay R, Harrison J: Nutritional and anthropometric assessment of patients on CAPD over one year: Contrasting changes in total body nitrogen and potassium. Perit Dial Bull 1:82–87, 1981.

    Google Scholar 

  187. Shaldon S, Koch KM, Quellhorst E, Dinarello CA: Pathogenesis of sclerosing peritonitis in CAPD. Trans Am Soc Artif Organs 30:193–194, 1984.

    CAS  Google Scholar 

  188. Burns RO, henderson LW: Peritoneal dialysis, clinical experience. N Engl J Med 267:1060–1066, 1962.

    PubMed  CAS  Google Scholar 

  189. Berlyne GM, Jones JH: Protein loss in peritoneal dialysis. Lancet 1:738–741, 1964.

    PubMed  CAS  Google Scholar 

  190. Gordon S, Rubini ME: Protein losses during peritoneal dialysis. Am J Med Sci 253:283–291, 1967.

    PubMed  CAS  Google Scholar 

  191. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW: Protein losses during peritoneal dialysis. Kidney Int 19:593–602, 1981.

    PubMed  CAS  Google Scholar 

  192. Giangrande A, Limido A, Cantu P, Aliaria P: SDS-polyacrylamide electrophoresis of protein loss during continuous ambulatory peritoneal dialysis. Ric Clin Lab 10:117–120, 1980.

    PubMed  CAS  Google Scholar 

  193. Katirtzoglou A, Oreopoulos DG, Husdan H, Leung M, Ogilvie R, Dombros N: Reappraisal of protein losses in patients undergoing continuous ambulatory peritoneal dialysis. Nephron 26:230–233, 1980.

    PubMed  CAS  Google Scholar 

  194. Diazbuxo JA, Walker PJ, Farmer CD, Chandler JT, Holt KL, Cox P: Continuous cyclic peritoneal dialysis. Trans Am Soc Artif Intern Organs 27:51–53, 1981.

    CAS  Google Scholar 

  195. Rubin J, Nolph KD, Arfania D, Prowant B, Fruto L, Brown P, Moore H: Protein losses in continuous ambulatory peritoneal dialysis. Nephron 28:218–221, 1981.

    Google Scholar 

  196. Twardowski Z, Ksiazek A, Majdan M, Janicka L, Bochens-ka-Nowacka E, Sokolowska G, Gutka A, Zbikowska A: Kinetics of continuous ambulatory peritoneal dialysis (CAPD) with four exchanges per day. Clin Nephrol 15:119–130, 1981.

    PubMed  CAS  Google Scholar 

  197. Randerson DH, Chapman GV, Farrell PC: Amino acid and dietary status in CAPD patients. In: RC Atkins, NM Thomson, PC Farrell, eds, Peritoneal Dialysis. Churchill Livingstone, London, pp 179–191, 1981.

    Google Scholar 

  198. Dulaney JT, Hatch FE: Peritoneal dialysis and loss of proteins: A review. Kidney Int 26:253–262, 1984.

    PubMed  CAS  Google Scholar 

  199. Fürst P, Bergström J, Lindholm B: Studies of amino acid metabolism in continuous ambulatory peritoneal dialysis patients — preliminary results. In: M Legrain, ed, Continuous Ambulatory Peritoneal Dialysis. Excerpta Medica, Amsterdam, pp 292–297, 1980.

    Google Scholar 

  200. Giordano C, DeSanto NG, Capodicasa G: Amino acid losses during CAPD. Clin Nephrol 14:230–232, 1980.

    PubMed  CAS  Google Scholar 

  201. Kopple JD, Blumenkrantz MJ, Jones MR, Moran JK, coburn JW: Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 36:395–402, 1982.

    PubMed  CAS  Google Scholar 

  202. Khanna R, Wu G, Rodella H, Oreopoulos DG: Use of amino acid containing solutions in CAPD patients. Pent Dial Bull 4:121–124, 1984.

    Google Scholar 

  203. Baeyer H von, Gahl GM, Riedinger H, Borowzak R, Averdunk R, Schurig R, Kessel M: Adaption of CAPD patients to the continuous peritoneal energy uptake. Kidney Int 23:29–34, 1983.

    Google Scholar 

  204. Rubin J, Kirchner K, Barnes T, Teal N, Ray R, Bower J: Evaluation of continuous ambulatory peritoneal dialysis. Am J Kidney Dis 3:199–204, 1983.

    PubMed  CAS  Google Scholar 

  205. Giordano C, DeSanto NG, Pluvio M: Protein requirements of patients on CAPD: A study of nitrogen balance. Int J Art Organs 3:11–16, 1980.

    CAS  Google Scholar 

  206. Gahl GM, Bayer HV, Averdunk R: Outpatient evaluation of dietary intake and nitrogen removal in continuous ambulatory peritoneal dialysis. Ann Intern Med 94:643–646, 1981.

    PubMed  CAS  Google Scholar 

  207. Committee On Dietary Allowances: Recommended Dietary Allowances. National Academy of Sciences, Washington DC, pp 1–15, 1980.

    Google Scholar 

  208. Oreopoulos DG, Crassweller P, Katirtzoglou A: Amino acids as an osmotic agent (instead of glucose) in continuous ambulatory peritoneal dialysis. In: M Legrain, ed, First International Symposium on CAPD, Paris 1979. Excerpta Medica, Amsterdam, pp 335–340, 1979.

    Google Scholar 

  209. Schilling H, Wu G, Pettit J, Mitwalli A, Anderson HG, Ogilve R, Oreopoulos DG: Use of amino acid containing solutions in continuous ambulatory peritoenal dialysis patients after peritonitis: Results of a prospective controlled trial. Proc Eur Dial Transpl Assoc-ER ERA 22:421–425, 1985.

    Google Scholar 

  210. Kopple JD: Abnormal amino acid and protein metabolism in uremia. Kidney Int 14:340–348, 1978.

    PubMed  CAS  Google Scholar 

  211. Committee on Dietary Allowances, Food and Nutrition Board: Recommended Dietary Allowances, 9th ed. National Academy of Sciences, Washington DC, pp 16–30, 1980.

    Google Scholar 

  212. Keys A, Brozek J, Hanschel A, Mielson O, Taylor HL: The Biology of Human Starvation. University of Minnesota Press, Minneapolis, p 1385, 1950.

    Google Scholar 

  213. Kopple JD, Monteon FJ, Shaib JK: Effect of energy intake on nitrogen metabolism in non-dialyzed patients with chronic renal failure. Kidney Int 29:734–742, 1986.

    PubMed  CAS  Google Scholar 

  214. Steefee WP: Nutritional support in renal failure. Surg Clin North Am 61:661–669, 1981.

    Google Scholar 

  215. Blumenkrantz MJ: Nutritional management of the adult patient undergoing peritoneal dialysis. J Am Diet Assoc 73:251–255, 1978.

    PubMed  CAS  Google Scholar 

  216. Lindholm B, Ahlberg M, Alvestrand A, Fürst P, Tranaeus A, Bergström J: Nitrogen balance and protein and energy intake during CAPD (abstract). In: Fourth Int. Congress on Nutrition and Metabolism in Renal Disease, 1985.

    Google Scholar 

  217. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Glucose absorption during continuous ambulatory peritoneal dialysis. Kidney Int 19:564–567, 1981.

    PubMed  CAS  Google Scholar 

  218. Attman PO, Gustafson A: Lipid and carbohydrate metabolism in uremia. Eur J Clin Invest 9:285–291, 1979.

    PubMed  CAS  Google Scholar 

  219. Attman PO: Long-term treatment with low protein diet in uremia. Contr Nephrol 53:128–136, 1986.

    CAS  Google Scholar 

  220. Bagdade JD, Yee E, Wilson DE, Shafrir E: Hyperlipidemia in renal failure. Studies of plasma lipoproteins, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat model. J Lab Clin Med 91:176–186, 1978.

    PubMed  CAS  Google Scholar 

  221. Modasini R, Frey F, Flury W, Klose G, Greten H: Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med 297:1362–1366, 1977.

    Google Scholar 

  222. Klose G, Ritz E, Weizel A, Greten H: Plasma lecithin-cholesterol acyltransferase (LCAT) activity and its relation to lipoprotein compositon in chronic hemodialysis (abstract). Eur J Clin Invest 10:111, 1980.

    Google Scholar 

  223. Gnasso A, haberbosch W, Augustin J, Ritz E: Abnormal lipoprotein metabolism in incipient renal failure. Proc Eur Dial Transpl Assoc-ERA 22:1129–1133, 1985.

    Google Scholar 

  224. Gofman JW, Young W, Tandy R: Ischemic heart disease, atherosclerosis, and longevity. Circulation 34:679–697, 1966.

    PubMed  CAS  Google Scholar 

  225. Goldberg AP, Harter MR, Patsch W, Schechtman KB, Province M, Weerts C, Kuisk I, McCrute MM, Schonfeld G: Racial differences in plasma high-density lipoproteins in patients receiving hemodialysis. N Engl J Med 308:1245–1252, 1983.

    PubMed  CAS  Google Scholar 

  226. Goldberg AP, Applebaum-Bowden DM, Bierman EL, Hazzard WR, Haas LB, Sherrad DJ, Brunzell JD, Huttunen JK, Ehnholm C, Nikkila EA: Increase in lipoprotein-lipase during Clofibrate treatment of hypertriglyceridemia in patients on hemodialysis. N Engl J Med 301:1073–1076, 1979.

    PubMed  CAS  Google Scholar 

  227. Goldberg A, Hurrad D, Haas L, Brunzell J: Control of Clofibrate toxicity in the treatment of uremic hyperlipemia. Clin Pharm Ther 21:314–319, 1977.

    Google Scholar 

  228. Sanfelippo ML, Swenson RS, Reaven GM, Reduction of plasma triglycerides by diet in subjects with chronic renal failure. Kidney Int 11:54–61, 1977.

    PubMed  CAS  Google Scholar 

  229. Sanfelippo ML, Swenson RS, Reaven GM: Response of plasma triglycerides to dietary change in patients on hemodialysis. Kidney Int 14:180–186, 1978.

    PubMed  CAS  Google Scholar 

  230. Cattran DC, Steiner G, Fenton SSA, Ampil M: Dialysis hyperlipemia: Response to dietary manipulations. Clin Nephrol 13:177–182, 1980.

    PubMed  CAS  Google Scholar 

  231. Okubo M, Tsukamoto Y, Yoneda T, Homma Y, Nakamura H, Marumo F: Deranged fat metabolism and the lowering effect of carbohydrate-poor diet on serum triglycerides in patients with chronic renal failure. Nephron 25:8–14, 1980.

    PubMed  CAS  Google Scholar 

  232. Phillipson BE, Rothrock DW, Connor WE, Harris WS, Illingworth DR: Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 3 (12):1210–1216, 1985.

    Google Scholar 

  233. Tsukamato Y, Okubo M, Yoneda T, Marumo F, Nakamura H: Effects of a polyunsaturated fatty acid-rich diet on serum lipids in patients with chronic renal failure. Nephron 31:236–241, 1982.

    Google Scholar 

  234. Ritz E, Augustin J, Bommer J, Gnasso A, Haberbosch W: Should hyperlipemia of renal failure be treated. Kidney Int 28 (Suppl 17):84–87, 1985.

    Google Scholar 

  235. Guarnieri GF, Ranieri F, Toigo G: Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis. Am J Clin Nutr 33:1489–1492, 1980.

    PubMed  CAS  Google Scholar 

  236. Bang HO, Dyerberg J, Sinclair HM: The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 33:2657–2661, 1980.

    PubMed  CAS  Google Scholar 

  237. Bang HO, Byerberg J, Hjorne N: The composition of food consumed by Greenland Eskimos. Acta Med Scand 200:69–73, 1976.

    PubMed  CAS  Google Scholar 

  238. Kromhout D, Bosschieter EB, Coulander C de L: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312:1205–1209, 1985.

    PubMed  CAS  Google Scholar 

  239. Hamazaki T, Nakazawa R, Tateno S, Shishido H, Isoda K, Hattori Y, Yoshida T, Fujita T, Yano S, Kumagai A: Effects of fish oil rich in eicosapentaenoic acid on serum lipid in hyperlipidemic hemodialysis patients. Kidney Int 26:81–84, 1984.

    PubMed  CAS  Google Scholar 

  240. Rylance PB, Gordge MP, Saynor R, Parsons V, Weston MJ: Fish oil modifies lipids and reduced platelet aggregability in hemodialysis patients. Nephron 43:196–202, 1986.

    PubMed  CAS  Google Scholar 

  241. Acker BAC van, Gilo HJG, Popp-Snijders C, van Bronswijk H, Rustemeijer C, Oe PL, Donker AJM: Free University Hospital, Amsterdam, The Netherlands. Kidney Int 31:255, 1987.

    Google Scholar 

  242. Glomset JA: Fish, fatty acids and human health. N Engl J Med 312:1253–1254, 1985.

    PubMed  CAS  Google Scholar 

  243. Herbert V: The vitamins: Folic acid and vitamin B12. In: RS Goodhart, ME Shils, eds, Modern Nutrition in Health and Disease, Lea and Febiger, Philadelphia, 1973.

    Google Scholar 

  244. Sullivan JF, Eisenstun AB: Ascorbic acid depletion during hemodialysis. JAMA 220:1697–1699, 1972.

    PubMed  CAS  Google Scholar 

  245. Blumberg A, Hauck A, Sander G: Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 20:244–250, 1983.

    PubMed  CAS  Google Scholar 

  246. Stone WJ, Warnock LG, Wagner C: Vitamin B6 deficiency in uremia. Am J Clin Nutr 28:950–957, 1975.

    PubMed  CAS  Google Scholar 

  247. Kopple JD, Mercurio K, Blumenkrantz MJ, Jones MR, Roberts C, Card B, Saltzman R, Casciato DA, SwenScid MA: Daily requirement for pyridoxine supplement in chronic renal failure. Kidney Int 19:694–704, 1981.

    PubMed  CAS  Google Scholar 

  248. Ito T, Niwa T, Matsiui E: Plasma flavin levels of patients receiving long-term hemodialysis. Clinica Chim Acta 39:125–129, 1972.

    CAS  Google Scholar 

  249. Food and Nutritional Board, National Academy of Sciences: Recommended dietary allowances. National Academy of Sciences, Washington DC, 1980.

    Google Scholar 

  250. Ramirez G, Chen M, boyce HW, Fuller SM, Butcher DE, Brueggemeyer CD, Newton JL: The plasma and red cell vitamin B levels of chronic hemodialysis patients: A longitudinal study. Nephron 42:41–46, 1986.

    PubMed  CAS  Google Scholar 

  251. DeBari VA, Frank O, Baker H: Water-soluble vitamins in granulocytes, erythrocytes, and plasma obtained from chronic hemodialysis patients. Am J Clin Nutr 39:410–415,1984.

    PubMed  CAS  Google Scholar 

  252. Dobblestein HW, Korner WF, Mempel W, Grosse-Wilde H, Edel HH: Vitamin B6 deficiency in uremia and its implications for the depression of immune responses. Kidney Int 5:233–237, 1974.

    Google Scholar 

  253. Blacke P, Schmidt P, Zazgornik J, Kopsa H: Reduction of elevated plasma oxalic acid levels by pyridoxine therapy in patients on regular dialysis therapy (abstract). Kidney Int 24 (Suppl 16): 346, 1983.

    Google Scholar 

  254. Raskin NH, Fishman RA: Pyridoxine-deficiency neuropathy due to hydralazine. N Engl J Med 273:1182–1185, 1965.

    PubMed  CAS  Google Scholar 

  255. Tsopas G, Magoula I, Paletas K, Concouris L: Effect of peritoneal dialysis on plasma levels of ascorbic acid. Nephron 33:34–37, 1983.

    Google Scholar 

  256. Pru C, Eaton J, Kjellstrand C: Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. Nephron 39:112–116, 1985.

    PubMed  CAS  Google Scholar 

  257. Day BR, Williams DR, Marsh CA: A rapid manual method for routine assay of ascorbic acid in serum and plasma. Clin Biochem 12:22–26, 1979.

    PubMed  CAS  Google Scholar 

  258. Eswara Dutt VVS, Mottola HA: Detection and initial rate determination of oxalic acid at the microgram level. Application to the analysis of humans blood serum and urine. Biochem Med 9:148–157, 1974.

    Google Scholar 

  259. Dziubinski JE: The effects of mega doses of ascorbic acid on bacterial activity and chemiluminescence production by human polymorphonuclear leukocytes. Thesis. University of Minnesota, Minneapolis, MN, 1979.

    Google Scholar 

  260. Ritchey EE, Wallin JD, Shah SV: Chemiluminescence and superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int 19:341–358, 1981.

    Google Scholar 

  261. Bennett B, Rosenblum BS: Identification of calcium oxalate crystals in the myocardium in patients with uremia. Lab Invest 10:947–955, 1961.

    CAS  Google Scholar 

  262. Macaluso MP, Berg NO: Calcium oxalate crystals in kidneys in acute tubular nephrosis and other renal diseases with functional failure. Institute of Pathology, University of Lund, Sweden, pp 197–205, 1959.

    Google Scholar 

  263. Hampers CL, Streiff R, Nathan DG, Snyder D, Merrill JP: Megaloplastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med 276:551–554, 1967.

    PubMed  CAS  Google Scholar 

  264. Hemmeloff Andersen KE: Folic acid status of patient with chronic renal failure maintained by dialysis. Clin Nephrol 8:510–513, 1977.

    Google Scholar 

  265. Minar E, Zazgornik J, Bayer PM, Landschützer H, Mengele K, Marosi: Hämatologische Veränderungen bei Patienten mit chronicher Hämodialyse — und Hämofiltrationsbehand-lung unter besonderer Berücksichtigung der Folsaure- und Vitamin B12- Serumkonzentrationen. Schweiz Med Wschr 114:48–53, 1984.

    PubMed  CAS  Google Scholar 

  266. Swainson CP: Do dialysis patients need extrafolate? Lancet 1:239, 1983.

    PubMed  CAS  Google Scholar 

  267. Schmücher H, Franz HE: Zur Frage der Behandlung einer hyperchromen Anämie mit Folsäure bei Patienten mit chronischer, dialysepflichtiger Niereninsuffizienz. In: Fortschritte in der Inneren Medizin. Springer, Berlin/Heidelberg/New York, 1982.

    Google Scholar 

  268. Kopple JD, SwendScid ME: Vitamin nutrition in patients undergoing maintenance hemodialysis. Kidney Int 7 (Suppl 2):79, 1975.

    Google Scholar 

  269. Smith FR, Goodman DS, The effects of diseases of the liver, thyroid and kidneys on the transport of vitamin A in human plasma. J Clin Invest 50:2426–2436, 1971.

    PubMed  CAS  Google Scholar 

  270. Vahlquist A, Berne B, Danielson BG, Grefberg N, Berne C: Vitamin A losses during continuous ambulatory peritoneal dialysis. Nephron 41:179–183, 1985.

    PubMed  CAS  Google Scholar 

  271. Yatzidis H, Digenis P, Fountas P: Hypervitaminosis — a accompanying advanced renal failure. Br Med J 1:352–353, 1975.

    Google Scholar 

  272. Vahlquist A, Berne B, Berne C: Skin content and plasma transport of vitamin A and ß-carotene in chronic renal failure. Eur J Clin Invest 12:63–67, 1982.

    PubMed  CAS  Google Scholar 

  273. Wieland RG, Hendricks FH, Amat Y, Leon F, Gutierrez L, Jones JC: Hypervitaminosis A with hypercalcemia. Lancet 1:698–701, 1971.

    PubMed  CAS  Google Scholar 

  274. Werb R, Clarke WF, Lindsay RM, Jones EOP, Linton AL: Serum vitamin A levels and associated abnormalities in patients on regular dialysis treatment. Clin Nephrol 12:63–68, 1979.

    PubMed  CAS  Google Scholar 

  275. Chertow BS, Williams GA, Norris RM, Baker GR, Hargis GK: Vitamin A stimulation of parathyroid hormone. Interactions with calcium, hydrocortisone and vitamin E in bovine parathyroid tissues and effects of Vitamin A in man. Eur J Clin Invest 7:307–314, 1977.

    PubMed  CAS  Google Scholar 

  276. Farrington K, Miller P, Varghese Z, Baillod RA, Moorhead JF: Vitamin A toxicity and hypercalcemia in chronic renal failure. Br Med J 282:1999–2002, 1981.

    CAS  Google Scholar 

  277. Rylance PB: Brown IRF, Howells DW, Nisbet JA, Stone AN, Eastwood JB: Relationship between vitamin A and bone disease in chronic renal failure. Nephron 36:131–135, 1984.

    PubMed  CAS  Google Scholar 

  278. Ono K: Effects of large dose vitamin E supplementation on anemia in hemodialysis patients. Nephron 40:440–445, 1985.

    PubMed  CAS  Google Scholar 

  279. Sinsakal V, Drake JR, Leavitt JM, Harrison BR, Fitch CD: Lack of effect of vitamin E therapy on the anemia of patients receiving hemodialysis. Am J Clin Nutr 39:223–226, 1984.

    Google Scholar 

  280. Lillo-Ferez M, Dopommereulle C, Prieur P, Petrover M: Inefficacy of vitamin E supplementation on anemia in hemodialysis patients. Nephron 45:79–80, 1987.

    PubMed  CAS  Google Scholar 

  281. Sandstead HH: Trace elements in uremia and hemodialysis. Am J Clin Nutr 33:1501–1508, 1980.

    PubMed  CAS  Google Scholar 

  282. Wallaeys B, Cornelis R, Mees L, Lameire N: Trace elements in serum, packed cells and dialysate of CAPD patients. Kidney Int 30:599–604, 1986.

    PubMed  CAS  Google Scholar 

  283. Bodgen JD, Zadzielski E, Weiner B, Oleske JM, Aviv A: Release of some trace methods from disponsible couils during hemodialysis. Am J Clin Nutr 36:403–409, 1982.

    Google Scholar 

  284. Bommer J: Deposits of silicone particles in organs of dialysis patients. Nieren- und Hochdruckkrankheiten 12:250–254, 1983.

    CAS  Google Scholar 

  285. Zumkley H, Bertram HP, Knok O, Graefe V, Lison A: Zinc and copper in chronic renal insufficiency. Nieren- und Hochdruckkrankheiten 12:221–224, 1983.

    CAS  Google Scholar 

  286. Smythe WR, Alfrey AL, Craswell PW, Ibels LS, Kubo H, Nunnelley LL: Trace elements abnormalities in chronic uremia. Ann Int Med 96:302–310, 1982.

    PubMed  CAS  Google Scholar 

  287. Aggett PJ: Zinc metabolism in chronic renal insufficiency without dialysis therapy. Contr Nephrol 83:95–102, 1984.

    Google Scholar 

  288. Atkin-Thor E, Goddard B, O’Nion J, Stephen RL, Kolff WJ: Hypogeusia and zinc depletion in chronic dialysis patients. Am J Clin Nutr 31:1948–1951, 1978.

    PubMed  CAS  Google Scholar 

  289. Condon CJ, freeman RM: Zinc metabolism in renal failure. Ann Int Med 73:531–536, 1970.

    PubMed  CAS  Google Scholar 

  290. Leung A, Henderson I, Halls D, Fell G, Kennedy AG: Trace element abnormalities in CAPD. Proc Eur Dial Transpl Assoc-ERA 22:410–414, 1985.

    Google Scholar 

  291. Sprenger KBG, Bundschuh D, Schmitz J, Franz HE: Therapy for zinc deficiency in dialysis patients. Nieren- und Hochdruckkrankheiten 12:230–234, 1983.

    Google Scholar 

  292. Mahajan SK, Prasad AS, McDonald FD: Sexual dysfunction in uremic man: Improvement following oral zinc supplementation. Contr Nephrol 38:103–111, 1984.

    CAS  Google Scholar 

  293. Brook AC, Johnston DG, Ward MK, Watson JM, Cook DB, Kerr DNS: Absence of a therapeutic effect of zinc in the sexual dysfunction of hemodialysed patients. Lancet 2:618–619, 1980.

    PubMed  CAS  Google Scholar 

  294. Antoniou LD, Shalhoup RJ: Zinc-induced enhancement of lymphocyte function and viability in chronic uremia. Nephron 40:13–21, 1985.

    Google Scholar 

  295. Salonen JT, Alfthen F, Hattunen JK, Puska P: Association between cardiovascular death and myocardial function and serum selenium in a matched-pair longitudinal study. Lancet 1:175–177, 1982.

    Google Scholar 

  296. Leung A, Henderson I, Fell G, Hall D, Kennedy AC: Selenium deficiency in chronic uremia and dialysis. Proc Eur Dial Transpl Assoc-ERA 22:1134–1138, 1985.

    Google Scholar 

  297. Koch K-M, Bechstein PB, Fassbinder W, Kaltwasser P, Schoeppe W, Werner E: Occult blood loss and iron balance in chronic renal failure. Proc Eur Dial Transpl Assoc 12:362–369, 1975.

    Google Scholar 

  298. Blumberg A, Marti HR, Graber Ch: Parameters for the assessment of iron metabolism in chronic renal insufficiency. Contr Nephrol 38:135–140, 1984.

    CAS  Google Scholar 

  299. Van de Vyrer FL, Vanheule AO, Verbueken AH, Haese PD, Visser WJ, Bekaert AB, van Grieken RE, Buyssens N, de Broe ME: Pattern of iron storage in patients with severe renal failure. Contr Nephrol 38:153–166, 1984.

    Google Scholar 

  300. Kothari T, Swamy AP, Lee JCK, Mangla JC, Cestero RVM: Hepatic hemosiderosis in maintenance hemodialysis patients. Dig Dis Sci 25:363–368, 1980.

    CAS  Google Scholar 

Download references

Authors
  1. Markus Teschner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. August Heidland
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Baylor College of Medicine, The Methodist Hospital, Houston, Texas, USA

    Wadi N. Suki

  2. Division of Nephrology, University of Southern California, Los Angeles, California, USA

    Shaul G. Massry

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Kluwer Academic Publishers

About this chapter

Cite this chapter

Teschner, M., Heidland, A. (1991). Nutritional Management of the Uremic Patient. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_44

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0689-4_44

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8027-9

  • Online ISBN: 978-1-4613-0689-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation